Annual Current Liabilities
$3.49 M
-$856.70 K-19.71%
December 1, 2023
Summary
- As of February 7, 2025, RNAZ annual total current liabilities is $3.49 million, with the most recent change of -$856.70 thousand (-19.71%) on December 1, 2023.
- During the last 3 years, RNAZ annual current liabilities has risen by +$3.09 million (+762.09%).
- RNAZ annual current liabilities is now -19.71% below its all-time high of $4.35 million, reached on December 31, 2022.
Performance
RNAZ Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$2.28 M
-$1.22 M-34.79%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ quarterly total current liabilities is $2.28 million, with the most recent change of -$1.22 million (-34.79%) on September 1, 2024.
- Over the past year, RNAZ quarterly current liabilities has dropped by -$3.31 million (-59.20%).
- RNAZ quarterly current liabilities is now -59.20% below its all-time high of $5.60 million, reached on September 1, 2023.
Performance
RNAZ Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
RNAZ Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.7% | -59.2% |
| 3 y3 years | +762.1% | +3.6% |
| 5 y5 years | +5449.4% | - |
RNAZ Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.7% | +37.8% | -59.2% | +32.2% |
| 5 y | 5-year | -19.7% | +5449.4% | -59.2% | +464.1% |
| alltime | all time | -19.7% | +5449.4% | -59.2% | +464.1% |
TransCode Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.28 M(-34.8%) |
| Jun 2024 | - | $3.50 M(+29.4%) |
| Mar 2024 | - | $2.71 M(-22.5%) |
| Dec 2023 | $3.49 M(-19.7%) | $3.49 M(-37.6%) |
| Sep 2023 | - | $5.60 M(+58.9%) |
| Jun 2023 | - | $3.52 M(-35.3%) |
| Mar 2023 | - | $5.45 M(+25.4%) |
| Dec 2022 | $4.35 M | $4.35 M(+15.3%) |
| Sep 2022 | - | $3.77 M(+118.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $1.73 M(-6.6%) |
| Mar 2022 | - | $1.85 M(-27.0%) |
| Dec 2021 | $2.53 M(+525.9%) | $2.53 M(+14.9%) |
| Sep 2021 | - | $2.20 M(+43.8%) |
| Jun 2021 | - | $1.53 M(+94.4%) |
| Mar 2021 | - | $788.80 K(+94.8%) |
| Dec 2020 | $404.90 K(+543.7%) | - |
| Dec 2020 | - | $404.90 K |
| Dec 2019 | $62.90 K | - |
FAQ
- What is TransCode Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for TransCode Therapeutics?
- What is TransCode Therapeutics annual current liabilities year-on-year change?
- What is TransCode Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly current liabilities year-on-year change?
What is TransCode Therapeutics annual total current liabilities?
The current annual current liabilities of RNAZ is $3.49 M
What is the all time high annual current liabilities for TransCode Therapeutics?
TransCode Therapeutics all-time high annual total current liabilities is $4.35 M
What is TransCode Therapeutics annual current liabilities year-on-year change?
Over the past year, RNAZ annual total current liabilities has changed by -$856.70 K (-19.71%)
What is TransCode Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of RNAZ is $2.28 M
What is the all time high quarterly current liabilities for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly total current liabilities is $5.60 M
What is TransCode Therapeutics quarterly current liabilities year-on-year change?
Over the past year, RNAZ quarterly total current liabilities has changed by -$3.31 M (-59.20%)